I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
prošli tjedan
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
prošli tjedan
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
prije 2 tjedna
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
prije 2 tjedna
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
prije 3 mjeseca
This too (and yh I DO wish I did this in CFD lol)
GGGGM
prije 3 mjeseca
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
prije 3 mjeseca
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
prije 3 mjeseca
What do we think
At a loss now, watching a bit
GGGGM
prije 3 mjeseca
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
prije 3 mjeseca
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
prije 3 mjeseca
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
prije 3 mjeseca
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Na ovoj se stranici možda nalazi sadržaj koji je izradila zajednica za koji platforma Trading 212 nije odgovorna. Uvijek sami provjerite sve informacije. Trading 212 pruža samo uslugu izvršenja i ne nudi investicijske savjete ili upravljanje portfeljem.
Izgradnja bogatstva je navika. Automatiziraj je pomoću pie.
Uloži u gotove pies ili stvori vlastite odabirom među tisućama dionica i ETF-ova
Saznaj više
Saznaj više
Pogledaj video
Kupi čak i najskuplje dionice kao što su Google, Amazon i Apple
Pogledaj video
Euronext Pariz
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londonska burza
Euronext Lisabon
Euronext Pariz
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londonska burza
Euronext Lisabon
Prikaži sve instrumente trgovanja
Podrška 24/7
Prosječno vrijeme odgovora iznosi 29 sekundi
Počni graditi svoje bogatstvo sada
Pridruži se zajednici od 5 milijuna korisnika
Preuzmi aplikaciju
Otvori račun
Preuzmi mobilnu aplikaciju
Svi prikazani statistički podaci su globalni. Broj klijenata predstavlja financirane račune.
Izvrsno
Ocjena 4,6 / 5 na osnovi 108.764 recenzije/a s platforme
Trustpilot
Ocjena 4,6 / 5 na osnovi 108.764 recenzije/a s platforme
Trustpilot
Pozvan
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Pozvan
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Pozvan
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Pozvan
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Pozvan
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Pozvan
How you rate the app
This app is so easy to use and safe really love it.
Pozvan
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Pozvan
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Pozvan
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Pozvan
Very good and informative always stay…
Very good and informative always stay on track with your investments
Pozvan
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Pozvan
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Pozvan
Very easy app to register and use
Very easy app to register and use! Really pleased.
Pozvan
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Pozvan
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Pozvan
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Pozvan
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Pozvan
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Pozvan
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Pozvan
Reliable
Reliable, Secure. Using it for past 3 years
Prikazuju se neke od pozitivnih recenzija naših klijenata
Naše nagrade
Česta pitanja
Koja je cijena dionice Capricor Therapeutics?
Trenutna cijena Capricor Therapeutics je 7,59 $.
Koji je 52-tjedni maksimum za Capricor Therapeutics?
52-tjedni maksimum za Capricor Therapeutics je 40,37 $.
Koji je 52-tjedni minimum za Capricor Therapeutics?
52-tjedni minimum za Capricor Therapeutics je 2,96 $.
Kakva je tjedna učinkovitost Capricor Therapeutics?
U proteklom tjednu cijena Capricor Therapeutics promijenila se za −20,36 %.
Kakva je mjesečna učinkovitost Capricor Therapeutics?
Tijekom proteklog mjeseca, cijena Capricor Therapeutics promijenila se za 14,14 %.
Kakva je 3-mjesečna performansa Capricor Therapeutics?
U posljednja tri mjeseca cijena Capricor Therapeutics promijenila se za −4,89 %.
Kakva je 6-mjesečna performansa Capricor Therapeutics?
U posljednjih šest mjeseci cijena Capricor Therapeutics promijenila se za −71,81 %.
Kakva je godišnja učinkovitost Capricor Therapeutics?
Tijekom protekle godine cijena Capricor Therapeutics promijenila se za 31,54 %.